{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibw2dpyofe2bjyxcwpyi5pggkaeni4377tadzgvzbv73w44htpcaq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mnwlbrxagzi2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia76mihw3n3fvrfedckqbxkjw4tooxazatt2pmf5nooqmtoaj4xae"
    },
    "mimeType": "image/jpeg",
    "size": 62670
  },
  "path": "/2026/06/09/biotech-news-gilead-and-merck-latest-trial-success-and-flop/?utm_campaign=rss",
  "publishedAt": "2026-06-09T15:11:54.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "AstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The Readout",
  "title": "Gilead and Merck’s latest trial success and flop",
  "updatedAt": "2026-06-09T15:11:59.000Z"
}